Changes in trial parameters.
Schwieterman
W D
WD
Weiss
K D
KD
Tiwari
J
J
Siegel
J P
JP
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D023181:Antimicrobial Cationic Peptides; D001798:Blood Proteins / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D008565:Membrane Proteins / Q000627:therapeutic use; D008589:Meningococcal Infections / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D012107:Research Design / Q000592:standards*; D018805:Sepsis / Q000188:drug therapy*
D000890:Anti-Infective Agents; D023181:Antimicrobial Cationic Peptides; D001798:Blood Proteins; D008565:Membrane Proteins; C021623:bactericidal permeability increasing protein